Controlled Release of Dopamine from a Polymeric Brain Implant:In Vivo Characterization
Ann Neurol 25:351-356, During,M.J.,et al, 1989
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989
Primary Lateral Sclerosis in a Child
Neurol 39:1530-1532, Grunnet,M.L.,et al, 1989
Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989
Respiratory Complications and Their Management in Motor Neuron Disease
Brain 112:1155-1170, Howard,R.S.,et al, 1989
DNA Restriction Fragment Length Polymorphisms in Diff Dx of Genetic Disease:Appl in Neuromusc Dis
Hum Genet 82:55-58, Defesche,J.C.,et al, 1989
Incidence of Guillain-Barre Syndrome During a Nationwide Oral Poliovirus Vaccine Campaign
Neurol 39:1034-1036, Kinnumen,E.,et al, 1989
Chronic Progressive Spinobulbar Spasticity, A Rare Form of Primary Lateral Sclerosis
Arch Neurol 45:509-513, Gastaut,J.L.,et al, 1988
Dopamine Agonists, In Parkinson's Disease and Movement Disorders
Urban & Schwarzenberg, Balt, p. 104., Jankovic,J.&Tolosa,E., 1988
Amyotrophic Lateral Sclerosis Presenting with Sleep Hypopnea Syndrome
Chest 93:1309-1312, Carre,P.C.,et al, 1988
Facioscapulohumeral Muscular Dystrophy, in Neuromuscular Disease
Springer-Verlag, NY, p289988., Swash,M.&Schwartz,M.S., 1988
PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988
The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988
Primary Lateral Sclerosis, A Clinical Diagnosis Reemerges
Arch Neurol 45:1304-1307, Younger,D.S.,et al, 1988
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
Amyotrophic Lateral Sclerosis, Recent Advances in Pathogenesis & Therapeutic Trials
Arch Neurol 45:189-202, Mitsumoto,H.,et al, 1988
The Natural History of Motoneuron Loss in Amyotrophic Lateral Sclerosis
Neurol 38:409-413, Munsat,T.L.,et al, 1988
Use of Composite Scores (Megascores) to Measure Deficit in Amyotrophic Lateral Sclerosis
Neurol 38:405-408, Andres,P.L.,et al, 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988
Acute Upper Airway Obstruction Due to Supraglottic Dystonia Induced by a Neuroleptic
BMJ 297:964-965, Newton-John,H., 1988
Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988
Pharmacotherapy for Aphasia
Neurol 38:877-879, Albert,M.L.,et al, 1988
A Double-Blind Randomized Crossover Trial of Bromocriptine & Placebo in Restless Legs Syndrome
Ann Neurol 24:455-458, Walters,A.S.,et al, 1988
Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis
Ann Neurol 23:418-420, Goodin,D.S.,et al, 1988
A Double-Blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Arch Neurol 45:381-386, Appel,S.H.,et al, 1988
Functional Recovery, A Major Risk Factor for the Development of Postpoliomyelitis Muscular Atrophy
Arch Neurol 45:645-647, Klingman,J.,et al, 1988
Motoneuron Disease and Past Poliomyelitis in England and Wales
Lancet 1:1319-1322, Martyn,C.N.,et al, 1988
Uneven Pattern of Dopamine Loss in the Striatum with Idiopathic Parkinson's Disease, Pathophysiologic & Clinical Implications
NEJM 318:876-880, Kish,S.J., 1988
Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987
Late Denervation in Patients with Antecedent Paralytic Poliomyelitis
NEJM 317:7-12, Cashman,N.R.,et al, 1987
Motor Neuron Disease in the US, 1971 & 1973-1978:Patterns of Mortality & Associated Conditions at Time of Death
Neurol 37:1339-1343, Leone,M.,et al, 1987
Clinincopath Conf
Progressive Muscular Atrophy & Diabetic Neuromuscular Disease, Case 21-1987, NEJM 316:1326-13357., , 1987
Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987
Incontinentia Pigmenti:Association with Anterior Horn Cell Degeneration
Neurol 37:446-450, Larsen,R.,et al, 1987
Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Motor Neuron Disease & Paraproteinemia
Neurol 37:335-337, Rudnicki,S.,et al, 1987
Current Status of Thyrotropin-Releasing Hormone Therapy in Amyotrophic Lateral Sclerosis
Comm. on Health Care Issues, Amer Neuro Assoc, Ann Neurol 22:541-54387., , 1987
A Rating Scale for Amyotrophic Lateral Sclerosis:Description & Preliminary Experience
Ann Neurol 22:328-333, Appel,V.,et al, 1987
Explanation & Management of Neurological Disability
BMJ 294:1203-1205, Critchley,E.M.R.&Mitchell,J.D., 1987
Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987
Diaphragm Pacing for Ventilatory Insufficiency
J Inten Care Med 2:345-353, Marcy,T.W.&Loke,J.S., 1987
Misdiagnosis of Myasthenia Gravis
J Nat'l Medical Assoc, 79:425-4291987., Wheeler,S.D., 1987
Classification of Peripheral Neuropathy:The Long and the Short of It
Muscle & Nerve 9:711-719986., Sabin,T.J., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986